![Dirk Haasner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dirk Haasner is the founder of 4-Antibody AG.
Formerly, VP-Regulatory, Medical Affairs & Policy at Lundbeck USA Inc. from 2002 to 2015.
Senior Vice President-Global Regulatory Affairs at Ovid Therapeutics, Inc. from 2015 to 2022.
Education includes a graduate degree from the University of Basel, conferred in 1991, and a doctorate from the Basel Institute for Immunology, conferred in 1994.
Anciens postes connus de Dirk Haasner
| Sociétés | Poste | Fin |
|---|---|---|
| OVID THERAPEUTICS INC. | Conseiller Juridique Général | - |
Lundbeck USA Inc. | Conseiller Juridique Général | 01/11/2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Fondateur | - |
Formation de Dirk Haasner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Basel Institute for Immunology
 Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck USA Inc. |
